Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-22-047887

SVP, Business Development acquired 1,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Birznieks Gunther SVP, Business Development 2022-08-26 Option exercise +1,250 $3.12 $3,900 190,057 D
Derivatives
Birznieks Gunther SVP, Business Development 2022-08-26 Option exercise · Employee Stock Option (Right to Buy) −1,250 0 D
Loading xslF345X03/doc4.xml…